Beximco Pharmaceuticals plc (BXP) GDR (Each Repr 1 Ord of BDT10)
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
No change
43.00p
n/a
51.50p
£191.83 million
43.00p
n/a
29.00p
8.50
0.00p (0.00%) Previous:
0.00p
n/a
6.09%
5,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2015 | 31/12/2014 |
|---|---|---|
| Revenue (¤m) | 12,965.51 | 11,206.89 |
| Profit before tax (¤m) | 2,337.13 | 2,109.56 |
| Adjusted EPS (¤): | 5.06 | 4.15 |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | 22.00 | 9.00 |
Values are quoted in the stock's local currency:
All fundamental dataRecent dividends paid or declared by Beximco Pharmaceuticals plc:
| Type | Ex-div date | Payment date | Amount |
|---|---|---|---|
| Final | 14/11/2017 | 18/01/2018 | 1.25 |
| Final | 11/05/2016 | 04/07/2016 | 1.00 |
This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.
Full dividend historyDividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
Company news for this stock is not available.
-
Change of Name to Beximco Pharmaceuticals PLC.
4 November 2025 07:00
-
Request of Extension to Publish Financial Results
27 October 2025 15:53
-
Affordable treatment option for cystic fibrosis
24 October 2025 07:00
Annual & interim reports
Annual & interim reports are not available for this stock.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.